Bio-Rad’s growing range of anti-idiotypic antibodies offers researchers enhanced flexibility for the development of custom bioanalytical drug assays
StarBright Violet 760, StarBright UltraViolet 575, and StarBright UltraViolet 605 Dyes conjugated to highly validated antibodies for multicolor panel design in immunology research
Highly sensitive droplet digital PCR-based liquid biopsies can detect the smallest amounts of residual cancer DNA and help oncologists refine treatment decisions for a variety of cancers
The system offers robust and precise quantification to improve nucleic acid detection for larger volume assay development
A wide selection of resins in new, convenient column format to support the development of protein purification workflows
The kit enables highly efficient, optimal RNA-Seq library preparation for comprehensive transcriptome profiling
System offers consistent, precise and accessible quantitative PCR analysis for singleplex and duplex assays
The StarBright UltraViolet 510, StarBright UltraViolet 665, and StarBright UltraViolet 795 Dyes offer enhanced brightness with narrow excitation and emission profiles to support multiplex panels
The new assays enable scientists to quickly measure neutralizing antibodies against SARS-CoV-2 virus
StarBright™ UltraViolet 400 Dye offers maximal brightness and narrow excitation and emission profiles for precise resolution
The panels complete Bio-Rad’s set of Bio-Plex™ Pro Multiplex SARS-CoV-2 Human Serology Panels for detection of antibodies against four SARS-CoV-2 antigens
ddPCR technology is recommended in the Centers for Disease Control and Prevention guidelines (CDC) for wastewater testing
The StarBright Violet 570, StarBright Violet 670, and StarBright Violet 710 Dyes offer precise excitation and emission spectra for improved brightness and resolution
The kit detects four hazardous Aspergillus species in cannabis flower
The antigen test is used to detect the nucleocapsid protein antigen in SARS-CoV-2
The assays will help public health researchers track SARS-CoV-2 variants more rapidly and cost-effectively
